Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1938 studies found for:    Farber's Disease
Show Display Options
Rank Status Study
21 Completed
Has Results
Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell Transplantation
Conditions: Graft Versus Host Disease;   GVHD
Interventions: Drug: tacrolimus;   Drug: sirolimus;   Drug: fludarabine;   Drug: busulfex
22 Completed Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy
Condition: Hodgkin's Disease
Interventions: Procedure: Pulmonary Function Tests;   Procedure: CAT Scan
23 Active, not recruiting Standard of Care vs. Bortezomib in Graft-Versus Host Disease After Hematopoietic Stem Cell Transplant
Condition: Graft Versus Host Disease
Interventions: Drug: Tacrolimus;   Drug: Methotrexate;   Drug: Bortezomib;   Drug: Sirolimus
24 Recruiting A Study of Lenalidomide for Adult Histiocyte Disorders
Conditions: Langerhans Cell Histiocytosis (LCH);   Histiocytoses Erdheim-chester Disease;   Histiocytic Sarcoma (HS)
Intervention: Drug: Lenalidomide
25 Completed
Has Results
Campath in Chronic GVHD
Condition: Chronic Graft-vs.-Host Disease
Intervention: Drug: Alemtuzumab (Campath)
26 Completed Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation
Conditions: Hematologic Malignancies;   Myelogenous Leukemia;   Acute Lymphoblastic Leukemia;   Myelodysplastic Syndrome;   Non-Hodgkin's Lymphoma;   Hodgkin's Disease
Interventions: Drug: Sirolimus;   Drug: Tacrolimus
27 Completed Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation
Conditions: Acute Myelogenous Leukemia;   Graft Versus Host Disease;   Acute Lymphoblastic Leukemia;   Chronic Myelogenous Leukemia;   Myelodysplastic Syndromes;   Non-Hodgkin's Lymphoma;   Hodgkin's Disease
Interventions: Drug: sirolimus;   Drug: tacrolimus
28 Recruiting An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease
Conditions: Chronic Graft-versus-Host-Disease;   Oral Mucosal Disease Due to Graft-versus-host Disease
Intervention: Drug: Sirolimus
29 Completed A Study of Gleevec in Patients With Idiopathic Myelofibrosis or Chronic Myelomonocytic Leukemia (CMML)
Conditions: Myelofibrosis;   Myeloid Metaplasia;   Agnogenic Myeloid Metaplasia;   Chronic Myelomonocytic Leukemia
Intervention: Drug: Imatinib mesylate
30 Completed Impact of Adnexal Involvement of the Severity and Prognosis of Chronic Graft-versus-Host Disease
Conditions: Graft vs Host Disease;   Chronic Graft vs Host Disease;   cGVHD
Intervention:
31 Completed
Has Results
Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Drug: Lexiscan
32 Unknown  Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease
Condition: Graft Versus Host Disease
Interventions: Biological: daclizumab;   Drug: methylprednisolone
33 Completed CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation
Conditions: Hematologic Malignancy;   AML;   ALL;   CML;   Multiple Myeloma;   NHL;   Hodgkin's Lymphoma
Intervention: Device: CD+8 T cell depletion
34 Unknown  Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation
Condition: Veno-Occlusive Disease
Intervention: Drug: defibrotide
35 Completed
Has Results
Efficacy of Vorinostat to Induce Fetal Hemoglobin in Sickle Cell Disease
Conditions: Sickle Cell Disease;   Sickle Cell Anemia
Intervention: Drug: vorinostat
36 Recruiting Gut Decontamination In Pediatric Allogeneic Hematopoietic
Conditions: Hematopoietic Stem Cell Transplantation (HSCT);   Acute GVH Disease
Intervention: Drug: Vancomycin-polymyxin B
37 Recruiting A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate Cancer
Condition: Prostate Cancer
Interventions: Device: Multiparametric MRI;   Procedure: Prostate biopsy
38 Recruiting Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders
Conditions: Multiple Myeloma;   Waldenstrom's Macroglobulinemia;   Smoldering Multiple Myeloma;   Lymphoblastic Lymphoma
Intervention:
39 Active, not recruiting Reduced Intensity Stem Cell Transplantation for Chronic Lymphocytic Leukemia Followed by Vaccination
Condition: Chronic Lymphocytic Leukemia
Interventions: Biological: GM-K562 vaccine;   Procedure: stem cell transplantation
40 Completed
Has Results
Rituximab for Prevention of Chronic GVHD
Condition: Hematological Malignancies
Interventions: Drug: Rituximab;   Drug: 375 mg/m2 RRituximab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.